$1.4 M

General Cannabis Revenue Q1, 2019
General Cannabis Gross profit (Q1, 2019)977.3 K
General Cannabis Gross profit margin (Q1, 2019), %70.3%
General Cannabis Net income (Q1, 2019)-4.5 M
General Cannabis EBIT (Q1, 2019)-3.2 M
General Cannabis Cash, 31-Mar-20195.6 M
General Cannabis EV32.3 M

General Cannabis Revenue

General Cannabis revenue was $3.93 m in FY, 2018

Embed Graph

General Cannabis Income Statement

Annual

USDFY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.8m3.0m3.5m3.9m

Cost of goods sold

115.2k77.0k380.6k590.6k

Gross profit

1.6m2.9m3.1m3.3m

Gross profit Margin, %

93%97%89%85%

General and administrative expense

1.4m2.0m2.8m4.6m

Operating expense total

9.0m10.0m10.6m16.0m

Depreciation and amortization

282.8k394.2k125.9k149.5k

EBIT

(7.2m)(7.1m)(7.0m)(11.4m)

EBIT margin, %

(411%)(237%)(200%)(290%)

Interest expense

300.7k5.5m313.1k326.0k

Net Income

(8.8m)(32.8m)(8.2m)(17.0m)

General Cannabis Balance Sheet

Annual

USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Cash

427.4k58.7k773.8k5.0m8.0m

Accounts Receivable

124.6k182.2k446.2k415.6k

Inventories

15.5k8.0k34.8k123.3k

Current Assets

429.7k245.5k1.1m6.2m9.0m

PP&E

452.8k1.7m1.7m1.3m1.5m

Goodwill

187.0k

Total Assets

882.4k3.7m2.9m7.6m10.7m

Accounts Payable

43.2k293.5k363.6k997.8k525.7k

Short-term debt

1.2m5.3m

Current Liabilities

46.1k3.7m23.5m4.1m6.2m

Long-term debt

1.2m5.3m

Total Debt

2.4m10.5m

Total Liabilities

389.3k3.9m25.7m4.1m

Additional Paid-in Capital

16.2m26.3m38.3m56.3m

Retained Earnings

(16.4m)(49.2m)(34.8m)(51.8m)

Total Equity

493.1k(208.2k)(22.9m)3.5m4.6m

Debt to Equity Ratio

0.7 x

Debt to Assets Ratio

0.3 x

Financial Leverage

1.8 x-17.7 x-0.1 x2.2 x2.4 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Cash

465.2k1.9m1.5m1.1m16.4k101.0k14.6k54.4k1.1m407.6k277.1k252.5k4.6m10.2m9.8m5.6m

Accounts Receivable

47.5k73.2k90.6k149.4k160.8k267.7k239.4k218.4k283.4k368.4k404.5k421.5k529.9k

Inventories

26.4k62.8k54.8k42.6k9.4k29.2k27.1k9.7k41.5k30.4k120.2k143.4k102.3k103.0k

Current Assets

473.5k1.9m1.6m1.2m249.0k345.9k190.0k264.4k1.4m766.1k702.2k740.3k5.3m11.6m10.7m7.2m

PP&E

457.9k458.0k489.9k1.7m1.7m1.7m1.7m1.7m1.7m1.7m1.7m1.4m1.4m1.4m1.6m

Goodwill

487.0k487.0k187.0k187.0k187.0k

Total Assets

473.5k2.5m2.2m1.8m3.9m3.9m3.5m3.5m4.6m2.6m2.6m2.8m7.0m13.3m12.2m9.3m

Accounts Payable

41.3k26.8k52.8k76.3k250.7k371.5k497.0k457.5k281.8k248.7k474.2k816.4k410.2k511.4k714.4k

Short-term debt

841.5k996.0k1.3m2.6m4.1m6.4m

Current Liabilities

61.8k1.2m984.4k1.1m2.4m3.6m4.2m3.7m17.9m12.5m8.1m8.9m887.9k3.3m4.9m7.7m

Long-term debt

657.5k841.5k996.0k1.3m2.6m4.1m6.4m

Total Debt

402.6k1.7m2.0m2.6m5.3m8.2m12.9m

Total Liabilities

61.8k1.8m1.8m2.0m3.9m4.9m4.4m3.9m18.5m14.7m10.4m8.9m887.9k7.8m

Additional Paid-in Capital

3.6m12.8m13.6m16.7m18.6m19.4m34.9m37.8m38.9m45.3m52.8m54.4m57.8m

Retained Earnings

(2.1m)(3.9m)(12.8m)(14.5m)(17.6m)(19.0m)(33.4m)(47.1m)(45.6m)(45.0m)(39.3m)(42.9m)(47.2m)(56.3m)

Total Equity

411.7k687.8k465.0k(167.7k)7.6k(917.7k)(861.1k)(376.0k)(13.9m)(12.1m)(7.8m)(6.1m)6.1m9.9m7.3m1.5m

Debt to Equity Ratio

0.6 x-0.4 x0.5 x

Debt to Assets Ratio

0.2 x0.9 x0.4 x

Financial Leverage

1.2 x3.7 x4.8 x-11 x510.2 x-4.3 x-4.1 x-9.3 x-0.3 x-0.2 x-0.3 x-0.5 x1.1 x1.3 x1.7 x6.2 x

General Cannabis Cash Flow

Annual

USDFY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(8.8m)(32.8m)(8.2m)(17.0m)

Depreciation and Amortization

282.8k394.2k125.9k149.5k

Accounts Receivable

(106.2k)(57.7k)(276.0k)(57.0k)

Inventories

67.1k7.5k(26.8k)(88.5k)

Accounts Payable

301.0k80.5k326.2k(311.6k)

Purchases of PP&E

(56.2k)(41.4k)(53.7k)(241.3k)

Cash From Investing Activities

(56.2k)(116.4k)393.6k(568.3k)

Long-term Borrowings

(6.3k)(917.3k)(1.6m)

Cash From Financing Activities

1.5m2.7m7.1m9.2m

Interest Paid

231.3k169.2k195.8k637.6k

General Cannabis Ratios

USDY, 2019

EV/EBIT

-10 x

Financial Leverage

6.2 x